PTC Therapeutics | PTCT - Market Capitalization


PTC Therapeutics reported $5.03B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
BioCryst Pharmaceuticals USD 1.7B 40M Mar/2026
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Cytokinetics USD 7.77B 1.19B Dec/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 475M 410M Mar/2026
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
Novartis USD 240.48B 51.73B Mar/2026
Pfizer USD 153.96B 12.4B Mar/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025
Xencor USD 1.09B 256M Dec/2025